Bo Li - Concepedia

Author

Bo Li

Guiyang Medical University ORCID

Also Known As

Bo Li, Li Bo, bo Li

Publications

228

Citations

H-Index

Concepts

All Affiliations

Guiyang Medical University Affiliated Hospital of Guizhou Medical University

About

Bo Li is an author at Guiyang Medical University specializing in cancer research, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	69
2	Cell Biology	4	4	69
3	Pathology	2	2	29
4	Health Sciences	1	1	27
5	Immunology	1	1	14

Bo Li

Publications

196

Citations

H-Index

Page 1

	Year	Citations
Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis Jiahui Ni, Lijie Zhang, Guize Feng, Pharmacological Research	2024	48
TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC Sibo Yang, Zihan Zhou, Lei Jin, Biology Direct	2023	31
<scp>DNASE1L3</scp> inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β‐catenin to promote its ubiquitin degradation pathway Bo Li, Yuzhen Ge, Weiwei Yan, Cell Proliferation Cell DeathCancer BiologyTumor BiologyCell RegulationCancer Cell Biology	2022	27
Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 Yongqin Zeng, Yuxing Yang, Cheng-Jing Guan, BMC Endocrine Disorders	2022	20
The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation Lifen Xu, Yüxia Zhou, Guifang Wang, Cell Death and Disease	2023	18
miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression Kun Cao, Bo Li, Yewei Zhang, Aging Cdkn2b ExpressionTumor BiologyAbnormal Mir-29b ExpressionMir-29b ExpressionDnmt3b-mediated Repression	2021	15
Thrombospondin 1 Triggers Osteosarcoma Cell Metastasis and Tumor Angiogenesis Yue Kui Jian, Huan Ye Zhu, Xing Lin Wu, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics AngiogenesisTumor GrowthImmunologyCancer GrowthPathology	2018	14
Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway Ye Chen, Rui Yan, Bo Li, International Urology and Nephrology Cell RegulationHigh Glucose-induced Proliferation-inhibitionApoptosisCell DeathMpc-5 Cells	2020	13
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC Peng Chen, Zheyu Dong, Wei Zhu, Hepatology	2023	10

Page 1